KBI Biopharma acquires Merck’s biomanufacturing facility in Colorado
KBI Biopharma has agreed to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado.
KBI Biopharma has agreed to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado.
Novasep has made a $5.5m (€4m) investment to expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at its Le Mans facility in France.